34 / 64
32
POSTERS
| PROGRAMME & EXHIBITION GUIDE
Role of L glutamine in reducing severity of chemoradiation induced
mucositis and improve QoL in HNC
V. Pareek (India), R. Bhalavat, M. Chandra
PO-085
Brachial plexus position reproducibility for head and neck radiotherapy
and its dosimetric impact
S. English (UK), A. Thompson
PO-086
Adaptive 18F-FDG-PET-guided reirradiation for recurrent and second
primary head and neck cancer
J. Schatteman (Belgium), D. Van Gestel, D. Berwouts, W. De Gersem, I. Goethals,
L. Olteanu, S. Rottey, T. Vercauteren, W. De Neve, F. Duprez
PO-087
The study of constant dose rate and gantry speed arc therapy for glottic
carcinoma on Varian 23EX
R. Zhang, Y. Gao, W. Bai (China), M. Miao, D. Liu
PO-088
Melatonin enhances the toxicity of radio- and chemotherapy in head and
neck cancer cells
G. Escames (Spain), B.I. Fernández-Gil, A. Guerra-Librero, Y. Shen,
S. García-López, J. Florido, R. Sayed, D. Acuña-Castroviejo, J. Esposito
PO-089
Oncostatic effect of melatonin in head and neck cancer: role of
mitochondrial function
G. Escames (Spain), A. Guerra-Librero, Y. Shen, J. Florido, R. Sayed,
M. Molina-Navarro, M. Gonzalez-Diez, D. Acuña-Castroviejo, J. Exposito
PO-090
Intensity modulated radiotherapy (IMRT) in nasopharyngeal cancer –
a dosimetric and QoL analysis
V. Pareek (India), R. Bhalavat, M. Chandra
PO-091
Dosimetric comparaison of conformal and intensity modulated
radiotherapy for locally recurrent NPC
W. Mnejja (Tunisia), L. Farhat, H. Daoud, T. Sahnoun, N. Fourati,
W. Siala, J. Daoud
PO-092
COSTAR trial results: 3-D Conformal Radiotherapy vs Cochlea-Sparing
IMRT in parotid cancer patients
C. Nutting, J. Morden, M. Beasley, S. Bhide (UK), M. Emson, M. Evans,
L. Fresco, D. Gujral, K. Harrington, C. Lemon, R. Neupane, K. Newbold,
R. Prestwich, M. Robinson, P. Sanghera, M. Sivaramalingam, M. Sydenham,
E. Wells, S. Witts, E. Hall
PO-093